1 – 18 of 18
- show: 50
- |
- sort: year (new to old)
- |
- Export
- 2020
- Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine (2020) NUCLEAR MEDICINE AND BIOLOGY. 86-87. p.20-29
- 2019
- New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma (2019) SCIENTIFIC REPORTS. 9.
- Validation of hepatobiliary transport PET imaging in liver function assessment : evaluation of 3β-[18F]FCA in mouse models of liver disease (2019) NUCLEAR MEDICINE AND BIOLOGY. 68-69. p.40-48
- In vivo measurement of hepatic drug transporter inhibition with radiolabeled bile acids (2019) Experimental cholestasis research. In Methods in Molecular Biology 1981. p.87-98
- Radiosynthesis, in vitro and in vivo evaluation of [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine as novel ASCT-2 directed tumor tracers (2019) Radiopharmaceutical Sciences, International symposium, Abstracts.
- 2018
- Evaluating hepatobiliary transport with 18F-labeled bile acids : the effect of radiolabel position and bile acid structure on radiosynthesis and in vitro and in vivo performance (2018) CONTRAST MEDIA & MOLECULAR IMAGING. 2018.
- Performance evaluation of the LightPath imaging system for intra-operative Cerenkov luminescence imaging (2018) PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 52. p.122-128
- Evaluating hepatobiliary transport with 18F labeled bile acids : the effect of radiolabel position and bile acid backbone on radiosynthesis, in vitro and in vivo performance (2018) European Molecular Imaging meeting, 13th, Abstracts.
- Evaluation of 3b-[18F]Fluorocholic acid in hepatocellular carcinoma bearing mice (2018) OncoPoint, 6th Research seminar, Abstracts.
- Radiosynthesis and in vivo evaluation of [18F] FABABA, a new ASCT-2 inhibitor (2018) European Molecular Imaging meeting, 13th, Abstracts.
- 18F Labeled bile acid analogues as molecular imaging tools to monitor hepatobiliary transport in drug-induced cholestasis and liver disease (2018)
- 2017
- Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice (2017) PLOS ONE. 12(3).
- In vitro characterization of the amino acid PET tracer 2-[18F]FELP and in vivo comparison to [18F]FET and [18F]FDG in a F98 glioblastoma rat model (2017) 18th Symposium of the Belgian Society of Nuclear Medicine, 5th to 7th May 2017, Ghent. p.1-1
- Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid, a radiolabeled bile acid to detect drug-induced cholestasis in preclinical drug development. (2017) 18th Symposium of the Belgian Society of Nuclear Medicine, 5th to 7th May 2017, Ghent. p.140-141
- 2016
- Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function (2016) NUCLEAR MEDICINE AND BIOLOGY. 43(10). p.642-649
- Evaluation of the LAT1 selective amino acid PET tracer 2-[18F]FELP in comparison to [18F]FET and [18F]FDG in a F98 glioblastoma rat model (2016) World Molecular Imaging Congress, Abstracts.
- Synthesis and in vivo PET evaluation of a 18F bile acid to assess drug-induced liver injury in mice (2016) MedChem 2016, Abstracts.
- Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid, a radiolabeled bile acid to detect drug-induced cholestasis in preclinical drug development (2016) World Molecular Imaging Congress, Abstracts.